Media formats available:
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDBenefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Clinical trials in T2DM & CVD: Review of key outcomes with GLP-1 RA and SGLT2i
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?